Pseudoarthrosis

2 papers1 finding

Humans1

Associations

1

SGLT2 inhibitors

downin humans1RR 0.73

1 study

SGLT2 inhibitors lower the risk of pseudoarthrosis in humans (4.9% vs. 6.8%; RR 0.73, 95% CI 0.55-0.97).
“At 1-year follow-up, patients receiving SGLT2i had lower rates of pseudoarthrosis (4.9% vs. 6.8%; RR 0.73, 95% CI 0.55-0.97; P=0.028).”
Humansundergoing ACDF1 year
Perioperative SGLT2 Inhibitor Use is Associated With Improved Outcomes After ACDF: A Propensity-matched Analysis
Spine5 Aug 2026

More on SGLT2 inhibitors

Latest

1 in 12 months

Spine6 Aug

Perioperative SGLT2 Inhibitor Use is Associated With Improved Outcomes After ACDF: A Propensity-matched Analysis

Cohort study of 1,585 peopleSGLT2 inhibitors

Diseases26 Mar

The Genetic and Biological Basis of Pseudoarthrosis in Fractures: Current Understanding and Future Directions

ReviewBones and joints

Immunity & Ageing14 Mar

Ageing attenuates bone healing by mesenchymal stem cells in a microribbon hydrogel with a murine long bone critical-size defect model

Experiments in animalsInterventions